This phenomenon is predominantly caused by cobalamin release during hepatic cytolysis and/or decreased cobalamin clearance by the affected liver
The correct interpretation of any result depends on the biological model, assay sensitivity, positive and negative controls, exposure period, analytical method, and the reproducibility of the dataset
Protocols describe using at least 1mL, ideally 2mL
National Library of Medicine) (2025) EGRIFTA SV (tesamorelin) Full Prescribing Information Theratechnologies, Inc
Ready to talk to a Rivas physician
Researchers who want to dig deeper into peptide handling alongside their orders can also explore the step-by-step reconstitution guide, the peptide storage guide, and the peptide degradation tutorial for laboratory best practices